HRMY   $38.933  1.55% Market Closed After Close 38.99 0.15%

Harmony Biosciences Holdings Inc
Total Cash 346.91M
totalCashPerShare 6.104
EBITDA 202.50M
Total Debt 189.06M
quickRatio 2.934
currentRatio 3.127
Total Revenue 656.11M
debtToEquity 35.104
Revenue/Share 11.325
ROA 0.13754
ROE 0.22465
grossProfits
freeCashflow 159.80M
operatingCashflow 213.52M
earningsGrowth -0.64
revenueGrowth 0.288
grossMargins 0.79413
ebitdaMargins 0.30864
operatingMargins 0.12358
profitMargins 0.17527
enterpriseValue 2.05B
forwardPE 10.466488
floatShares 34.68M
sharesOutstanding 56.83M
sharesShort 8.76M
sharesShortPriorMonth 8.40M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.94%
Short Ratio help_outline 27.79%
shortPercentOfFloat 0.69%
impliedSharesOutstanding
bookValue 9.476
Price To Book help_outline 4.12
earningsQuarterlyGrowth -0.66
netIncomeToCommon 114.99M
trailingEps 1.95%
forwardEps 3.73%
enterpriseToEbitda 10.14
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.66 3Q 2024
institutionsCount 323
lastUpdated Sept. 16, 2024, 8 p.m.